Cargando…
Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension
Evidence has shown that angiotensin II type 1 receptor antagonists have lower blood pressure and have target organ protective effects, but this is not the case for the drug allisartan isoproxil. The aim of this study was to evaluate the effects of allisartan isoproxil on blood pressure and target or...
Autores principales: | Zhang, Jian-Qi, Yang, Guo-Hong, Zhou, Xin, Liu, Jun-Xiang, Shi, Rui, Dong, Yan, Chen, Shao-Bo, Li, Yu-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708765/ https://www.ncbi.nlm.nih.gov/pubmed/30896643 http://dx.doi.org/10.1097/MD.0000000000014907 |
Ejemplares similares
-
A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk
por: Li, Ying, et al.
Publicado: (2015) -
Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF-κB signalling pathway in diabetic cardiomyopathy rats
por: Jin, Qinyang, et al.
Publicado: (2021) -
Allisartan ameliorates vascular remodeling through regulation of voltage-gated potassium channels in hypertensive rats
por: Zhang, Xiaoqin, et al.
Publicado: (2021) -
Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in Korea
por: Kim, Dae-Hee, et al.
Publicado: (2010) -
Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension
por: Shin, Mi-Seung, et al.
Publicado: (2016)